Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.

Adam Strzelczyk; Milka Pringsheim; Thomas Mayer; Tilman Polster; Kerstin A Klotz; Hiltrud Muhle; Michael Alber; Regina Trollmann; Hartwig Spors; Gerhard Kluger; Gerhard Kurlemann; Susanne Schubert-Bast

doi:10.1111/epi.17034

Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.

Adam Strzelczyk, Milka Pringsheim (Co-author), Thomas Mayer, Tilman Polster, Kerstin A Klotz, Hiltrud Muhle, Michael Alber, Regina Trollmann, Hartwig Spors, Gerhard Kluger (Co-author), Gerhard Kurlemann, Susanne Schubert-Bast

Research output: Contribution to journal › Original Article › peer-review

21 Citations (Web of Science)

Original language	English
Pages (from-to)	2518-2527
Journal	EPILEPSIA
Volume	62
Issue number	10
DOIs	https://doi.org/10.1111/epi.17034
Publication status	Published - 2021

Keywords

ILAE COMMISSION
POSITION PAPER
CLASSIFICATION
EPILEPSY

Access to Document

10.1111/epi.17034

Cite this

Strzelczyk, A., Pringsheim, M., Mayer, T., Polster, T., Klotz, K. A., Muhle, H., Alber, M., Trollmann, R., Spors, H., Kluger, G., Kurlemann, G., & Schubert-Bast, S. (2021). Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany. EPILEPSIA, 62(10), 2518-2527. https://doi.org/10.1111/epi.17034

@article{589cbf7115ea4f979bc0e9dfb51554ca,

title = "Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.",

keywords = "ILAE COMMISSION, POSITION PAPER, CLASSIFICATION, EPILEPSY",

author = "Adam Strzelczyk and Milka Pringsheim and Thomas Mayer and Tilman Polster and Klotz, {Kerstin A} and Hiltrud Muhle and Michael Alber and Regina Trollmann and Hartwig Spors and Gerhard Kluger and Gerhard Kurlemann and Susanne Schubert-Bast",

note = "Pringsheim, Kluger: Epilepsy Ctr Children *** Adolescents, Schon Clin Vogtareuth, Clin Neuropediat *** Neurorehabil, Vogtareuth, Germany; Kluger: Paracelsus Med Univ Salzburg, Res Inst, Rehabil Transit *** Palliat, Salzburg, Austria;",

year = "2021",

doi = "10.1111/epi.17034",

language = "English",

volume = "62",

pages = "2518--2527",

journal = "EPILEPSIA",

issn = "0013-9580",

publisher = "Wiley Verlag ",

number = "10",

}

Strzelczyk, A, Pringsheim, M, Mayer, T, Polster, T, Klotz, KA, Muhle, H, Alber, M, Trollmann, R, Spors, H, Kluger, G, Kurlemann, G & Schubert-Bast, S 2021, 'Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.', EPILEPSIA, vol. 62, no. 10, pp. 2518-2527. https://doi.org/10.1111/epi.17034

TY - JOUR

T1 - Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.

AU - Strzelczyk, Adam

AU - Pringsheim, Milka

AU - Mayer, Thomas

AU - Polster, Tilman

AU - Klotz, Kerstin A

AU - Muhle, Hiltrud

AU - Alber, Michael

AU - Trollmann, Regina

AU - Spors, Hartwig

AU - Kluger, Gerhard

AU - Kurlemann, Gerhard

AU - Schubert-Bast, Susanne

N1 - Pringsheim, Kluger: Epilepsy Ctr Children *** Adolescents, Schon Clin Vogtareuth, Clin Neuropediat *** Neurorehabil, Vogtareuth, Germany; Kluger: Paracelsus Med Univ Salzburg, Res Inst, Rehabil Transit *** Palliat, Salzburg, Austria;

PY - 2021

Y1 - 2021

KW - ILAE COMMISSION

KW - POSITION PAPER

KW - CLASSIFICATION

KW - EPILEPSY

U2 - 10.1111/epi.17034

DO - 10.1111/epi.17034

M3 - Original Article

C2 - 34378197

SN - 0013-9580

VL - 62

SP - 2518

EP - 2527

JO - EPILEPSIA

JF - EPILEPSIA

IS - 10

ER -